Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J D Talley

Showing results (131-140 of 153) with videos related to

Pageof 16
Sort By:
Journal of Thrombosis and Thrombolysis|December 10, 1999
Inhibition of platelet aggregation with a glycoprotein IIb-IIIa antagonist does not prevent thrombin generation in patients undergoing thrombolysis for acute myocardial infarctionN S Kleiman, R P Tracy, J D Talley, et al.
Circulation|April 1, 1988
Clinical outcome 5 years after attempted percutaneous transluminal coronary angioplasty in 427 patientsJ D Talley, J W Hurst, S B King, et al.
Journal of the American College of Cardiology|August 26, 1998
Influence of insurance type on the use of procedures, medications and hospital outcome in patients with unstable angina: results from the GUARANTEE Registry. Global Unstable Angina Registry and Treatment EvaluationN R Every, C P Cannon, C Granger, et al.
Journal of the American College of Cardiology|October 1, 1995
Peripheral vascular complications in the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT-I)N A Omoigui, R M Califf, K Pieper, et al.
Catheterization and Cardiovascular Diagnosis|April 1, 1991
Multicenter evaluation of a new fixed-wire coronary angioplasty catheter system: clinical and angiographic characteristics and resultsJ D Talley, A Joseph, E S Killeavy, et al.
Circulation|July 1, 1994
Intravenous Fluosol in the treatment of acute myocardial infarction. Results of the Thrombolysis and Angioplasty in Myocardial Infarction 9 Trial. TAMI 9 Research GroupT C Wall, R M Califf, J Blankenship, et al.
Journal of the American College of Cardiology|October 1, 1996
Increased risk of non-Q wave myocardial infarction after directional atherectomy is platelet dependent: evidence from the EPIC trial. Evaluation of c7E3 for the Prevention of Ischemic ComplicationsJ Lefkovits, J C Blankenship, K M Anderson, et al.
The New England Journal of Medicine|November 17, 1994
Lack of effect of lovastatin on restenosis after coronary angioplasty. Lovastatin Restenosis Trial Study GroupW S Weintraub, S J Boccuzzi, J L Klein, et al.
Circulation|August 1, 1994
Use of aortic counterpulsation to improve sustained coronary artery patency during acute myocardial infarction. Results of a randomized trial. The Randomized IABP Study GroupE M Ohman, B S George, C J White, et al.
Journal of the American College of Cardiology|September 14, 2000
Outcome and profile of ventricular septal rupture with cardiogenic shock after myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK?V Menon, J G Webb, L D Hillis, et al.
Pageof 16

Showing results (131-140 of 153) with videos related to

Sort By:
Pageof 16
Journal of Thrombosis and Thrombolysis|December 10, 1999
Inhibition of platelet aggregation with a glycoprotein IIb-IIIa antagonist does not prevent thrombin generation in patients undergoing thrombolysis for acute myocardial infarctionN S Kleiman, R P Tracy, J D Talley, et al.
Circulation|April 1, 1988
Clinical outcome 5 years after attempted percutaneous transluminal coronary angioplasty in 427 patientsJ D Talley, J W Hurst, S B King, et al.
Journal of the American College of Cardiology|August 26, 1998
Influence of insurance type on the use of procedures, medications and hospital outcome in patients with unstable angina: results from the GUARANTEE Registry. Global Unstable Angina Registry and Treatment EvaluationN R Every, C P Cannon, C Granger, et al.
Journal of the American College of Cardiology|October 1, 1995
Peripheral vascular complications in the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT-I)N A Omoigui, R M Califf, K Pieper, et al.
Catheterization and Cardiovascular Diagnosis|April 1, 1991
Multicenter evaluation of a new fixed-wire coronary angioplasty catheter system: clinical and angiographic characteristics and resultsJ D Talley, A Joseph, E S Killeavy, et al.
Circulation|July 1, 1994
Intravenous Fluosol in the treatment of acute myocardial infarction. Results of the Thrombolysis and Angioplasty in Myocardial Infarction 9 Trial. TAMI 9 Research GroupT C Wall, R M Califf, J Blankenship, et al.
Journal of the American College of Cardiology|October 1, 1996
Increased risk of non-Q wave myocardial infarction after directional atherectomy is platelet dependent: evidence from the EPIC trial. Evaluation of c7E3 for the Prevention of Ischemic ComplicationsJ Lefkovits, J C Blankenship, K M Anderson, et al.
The New England Journal of Medicine|November 17, 1994
Lack of effect of lovastatin on restenosis after coronary angioplasty. Lovastatin Restenosis Trial Study GroupW S Weintraub, S J Boccuzzi, J L Klein, et al.
Circulation|August 1, 1994
Use of aortic counterpulsation to improve sustained coronary artery patency during acute myocardial infarction. Results of a randomized trial. The Randomized IABP Study GroupE M Ohman, B S George, C J White, et al.
Journal of the American College of Cardiology|September 14, 2000
Outcome and profile of ventricular septal rupture with cardiogenic shock after myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK?V Menon, J G Webb, L D Hillis, et al.
Pageof 16